Sharps Technology, Inc. (NASDAQ:STSS) Short Interest Update

Sharps Technology, Inc. (NASDAQ:STSS) was the target of a significant increase in short interest in February. As of February 15th, there was short interest totalling 899,200 shares, an increase of 110.0% from the January 31st total of 428,100 shares. Currently, 70.3% of the company’s stock are short sold. Based on an average daily volume of 3,140,000 shares, the days-to-cover ratio is presently 0.3 days.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of STSS. Garden State Investment Advisory Services LLC purchased a new position in Sharps Technology in the third quarter worth about $26,000. Essential Planning LLC. boosted its position in Sharps Technology by 22.7% in the fourth quarter. Essential Planning LLC. now owns 199,854 shares of the company’s stock worth $412,000 after purchasing an additional 37,029 shares during the last quarter. Finally, Anson Funds Management LP purchased a new position in shares of Sharps Technology during the 4th quarter valued at about $76,000. 17.17% of the stock is owned by hedge funds and other institutional investors.

Sharps Technology Trading Down 6.3 %

Shares of NASDAQ:STSS traded down $0.02 on Friday, hitting $0.28. 1,752,872 shares of the company traded hands, compared to its average volume of 5,126,340. Sharps Technology has a 52 week low of $0.26 and a 52 week high of $18.15. The business has a 50 day moving average price of $1.19. The company has a market capitalization of $1.57 million, a P/E ratio of -0.04 and a beta of 1.41.

About Sharps Technology

Sharps Technology, Inc, a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc was incorporated in 2017 and is based in Melville, New York.